Transcriptomics Technologies Market Worth $6.9 Billion By 2022

The global transcriptomics technologies market is expected to reach USD 6.9 billion by 2022, according to a new report by Grand View Research Inc. The increasing demand for genetic identification and growing investment in R&D innovation along with the technological advancements across the product portfolio are the vital driving forces of this market. The increasing R&D investments are expected to highly influence biotechnological research and develop commercialization over the forecast period. The rising investment is further anticipated to ensure positive growth and enhance business opportunities for pharmaceutical and biotechnological companies. 

Furthermore, the rising demand for efficient diagnostic methods drives the need for personalized medicines. Transcriptomics tools and the offered services identify potential drug targets, which are effective methods for diagnostic methodologies. The shifting preference of pharmaceutical companies towards therapeutics results in rising demand for disease-specific biomarker identification. This change ensures a potential opportunity in the commercialization of transcriptome research results. The escalating demand for efficient diagnostics and treatment measures in the areas of oncology, HIV, Alzheimer’s disease, etc., also contributes significantly towards transcriptomics technologies market growth. 

Click the link below:
http://www.grandviewresearch.com/industry-analysis/transcriptomics-technologies-market

Further key findings from the report suggest:

  • Polymerase Chain Reaction (PCR) based transcriptomics technologies market is expected to account for over 40% market share by 2022 owing to its ability to enable amplification even from very small amounts of genetic material samples
  • Next-generation Sequencing based transcriptomics technologies market is expected to grow at a lucrative CAGR of over 17.0% over the forecast period owing to increased outsourcing of sequencing technologies, upgrading of technology enabling the analysis of cellular transcriptome from various dimensions, and wide application areas of NGS
  • North America dominates the transcriptomics technologies market in terms of revenue owing to the increasing R&D activities by the biotechnology and pharmaceutical companies
  • North America and Asia Pacific are expected to witness the fastest growth of over 15.0% during the forecast period. The growth is due to the presence of untapped opportunities, rising expenditure levels, and the introduction of favorable government initiatives.
  • Key players of transcriptomics technologies market include Agilent Technologies, Affymetrix, Thermo Fisher Scientific, Illumina, Life Technologies, and F. Hoffmann-La Roche
  • Market participants are constantly engaged in strategic collaborations such as mergers and acquisitions along with technological advancements in an attempt to improve presence and ensure sustainability
  • For instance, in May 2015, Agilent Technologies announced the acquisition of Cartagenia that provides services and software for clinical genetic analysis. Their products are supplied to pathology laboratories and clinical research institutes. The acquisition is expected to provide higher integration and support customer satisfaction. 

Scanning Electron Microscope Market Size Worth $2.9 Billion By 2022

The global scanning electron microscopes market is expected to reach USD 2.9 billion by 2022, according to a new report by Grand View Research, Inc. Rising demand for nanotechnology-based research and growing R&D innovation in application areas are anticipated to serve as key growth drivers.

Rapid growth witnessed in application areas such as semiconductors, automobiles, pharmaceuticals, and nanotechnology globally are some the key factor responsible for the significant growth of SEM market.

Technological advancements in scanning electron microscopy (SEM) improves the quality control procedures of research laboratories in wide range of industries such as semiconductors, automobiles to pharmaceutical manufacturing. Scanning electron microscopy play a critical role in imaging and elemental analysis of products. However, the advanced SEMs offer advantages such as rapid analysis, compact size and efficient results with higher resolution and 3D imaging.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/scanning-electron-microscope-market

Further key findings from the study suggest:

  • Application of SEM in pharmaceuticals is expected to account for over 30.0% share by 2022 owing to, the increasing prevalence of chronic diseases leading to increased R&D expenditure and demand for digital microscopes in the fields of life sciences and medicine.
  • Application of SEM in automobiles is expected to grow at a lucrative CAGR of over 11.0% over the forecast period. Increasing demand of SEM in surface observation, film thickness analysis and coating analysis is expected to drive demand.
  • Asia Pacific is expected to dominate the market by 2022 at over 35.0%, due to the presence of world class manufacturers for scanning electron microscopes in this region and increasing usage of SEM for elemental analysis and imaging.
  • Growing demand for advanced scanning electron microscopes for the range of material research is expected to boost the SEM market in Latin America which is expected to grow at a CAGR of 11.6% over the forecast period.
  • Some key players of this market include Bruker Corporation, Danish Micro Engineering (DME), FEI Company, Hitachi High Technologies Corporation, JEOL Ltd., Leica Microsystems, Nanoscience Instruments, Inc., Nikon Corporation, Olympus Corporation, Tescan Orsay Holding and Carl Zeiss.
  • New product launches such as out-lens type thermal-electron gun scanning electron microscope by Hitachi High Technologies Corporation is also likely to serve as a viable sustainability strategy.

Application Management Services Market Worth $87.60 Billion By 2025

The global application management services market size is estimated to reach USD 87.60 billion by 2025, according to a new report by Grand View Research, Inc. The industry is expected to witness a steady growth owing to the increasing demand from the financial services sector and healthcare industry.

Application management services encompass a wide range of implementation and operational services that are vital to application maintenance, optimization, support and modernization, and migration. As the number of applications used and deployed by organizations is increasing continuously, the need to monitor and manage these services for business efficiency and continuity is driving the demand for application services across different industries.

Companies today make use of a myriad set of applications to address client needs, deal with numerous stakeholders in the value chain, and keep abreast with the rapidly evolving technology landscape. These conditions have been augmented with the advent of new trends such as Internet of Things, cloud, and analytics, which are disrupting the traditional system models. Owing to these factors, the application management services are anticipated to witness a steady rise in demand over the years to come.

The application services market is quite mature, which can be attributed to the presence of many traditional service providers who are entrenched firmly in the market. As the technological adoption gains velocity in the industry, delivery models and service scopes are set to exhibit a dramatic change with Software as a Service and cloud deployments playing a significant role in the market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/application-management-services-market

Further key findings from the report suggest:

  • The industry is marked by the presence of big enterprises such as Cognizant, Accenture, IBM, Capgemini, and Deloitte
  • The banking, financial services, and insurance segment is anticipated exhibit a significant increase in demand
  • IT cost reduction, digitalization, and the need for gaining agility, reliability, and integrated system models will shape the nature of services provided and sought after in the market
  • The impact of changing industry dynamics will be profoundly exhibited on outsourcing, whether offshoring or onshoring industries, at a global level
  • The lack of innovation, communication gaps, and inefficient methods for change management and governance may become major hurdles in the industry’s growth over the forecast period

Customer Experience Management Market Size $23.6 Billion By 2027

The global customer experience management market size is expected to reach USD 23.6 billion by 2027, registering a CAGR of 17.7% from 2020 to 2027, according to the new study conducted by Grand View Research, Inc. The digital disruption and changing customer behavior are some of the key trends stimulating the growth of the market for customer experience management. Furthermore, with the increasing expectation of customers for quality, convenience, and speed service, business organizations are engaged to provide services at multiple touch points. Additionally, with the advancements in technology, organizations are actively involved in the implementation and deployment of autonomous and AI-based platforms and applications to provide fast, reliable, and efficient real-time customer service.

Rise in social media platforms and online commerce business is another factor responsible for the traction of contextualized and personalized consumer experience through data management. Consumers share every experience and their opinions across different channels. The result of sharing opinions could impact a brand’s reputation positively or negatively. Therefore, to improve brand loyalty, reputation, and to retain customer, business organizations are transforming their business model towards more of a customer-centric approach to gain a competitive edge ahead and provide efficient customer experience.

The opportunity for customer experience management increases with the implementation of cloud-based deployment models. It maintains, unify, and provides a holistic view of customer information throughout the organizational ecosystem. Furthermore, the information connected within a single cloud offers different departments and business functions to closely monitor a lead, understand consumer preferences, and their expenditure behaviors and buying patterns before facilitating any personalized marketing strategies. The adoption of such consumer experience management practices also eliminates information siloes and help organization enrich its consumer experience management, in turn, gaining customer loyalty.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/customer-experience-management-market

Further key findings from the report suggest:

  • Based on the analytical tools segment, text analytics held the largest customer experience management market share in 2019. The growth in the segment is attributed to the increasing demand to understand unstructured text-based data and gain valuable insights through social media comments and product reviews
  • The mobile touchpoint segment is anticipated to witness a highest CAGR over the forecast period. This growth is attributed to the rising use of mobile devices among customers, increasing number of mobile apps, and growth in mobile marketing and personalized marketing strategies
  • On the basis of end-user segment, the BFSI segment is expected to register the highest CAGR of 19.0% over the forecast period
  • North America accounted for the largest revenue share in 2019 and is expected to continue to dominate the market for customer experience management over the forecast period
  • The key industry participants include Adobe; Avaya Inc.; IBM; Genesys; Open Text Corporation; Oracle; SAP SE; and Verint.

Application Delivery Controller Market Worth $4.34 Billion By 2024

The global application delivery controller (ADC) market is expected to reach USD 4.34 billion by 2024, according to a new report by Grand View Research, Inc. The application delivery controller market is anticipated to witness a high growth over the forecast period. This may be accredited to the increasing globalization and distributed enterprise architecture, which requires networks that can deliver their business-critical applications faster, thereby ensuring security. The increase in the data center traffic and the growing ADC popularity, particularly in the consolidated data center segment, are expected to be the major factors spurring the ADC market growth over the forecast period.

The increasing adoption of the BYOD phenomenon has led to the widespread usage of tablets and smartphones particularly in large organizations as it significantly increases the scope and span of enterprises. This, in turn, has resulted in a rise in the ADC demand in order to balance and maintain the server load. In addition, emerging technologies, such as software-defined storage (SDS) and software-defined networking (SDN), are also anticipated to spur the ADC market growth over the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/application-delivery-controller-market

Further key findings from the report suggest:

  • The virtual segment captured over 30% of the total revenue share in 2015 and is anticipated to exhibit growth exceeding 5.0% from 2016 to 2024. This can be attributed to the improved IT agility, performance, and cost benefits offered by them over the hardware-based ADCs as well as the increasing cloud-based data center traffic.
  • The small & medium enterprise (SME) segment is expected to gain prominence over the forecast period exceeding a compound annual growth rate of 5% from 2016 to 2024. This is ascribed to the increasing adoption of web-enabled services and web-based apps for running their business as well as to the proliferation of internet-enabled devices.
  • The IT & telecom segment accounted for a significant revenue share in 2015 capturing over 25% of the overall revenue share in the same year. The segment is expected to grow at a CAGR exceeding 5.5% from 2016 to 2024. This is majorly due to the integration of ADCs into enterprise IT systems to enhance efficiency.
  • Asia Pacific is expected to emerge as the fastest growing segment accounting for more than 20% of the overall share in 2015. This growth is due to increasing investments in the IT infrastructure, primarily in China and India. Furthermore, the rising demand in this region can be ascribed to the high market penetration, owing to the webification of organizational applications along with the growing ADC application in server firewalls and network security systems.
  • The key application delivery controller market purveyors comprise F5 Networks Inc., Citrix Systems, A10 Networks Inc., Array Networks, Inc., and Brocade Communications Systems, Inc. Companies, with their extensive distribution channels and worldwide presence, lay emphasis on adopting the best practices for developing solutions to achieve competitive advantage in this industry.

Architectural Services Market Size Worth $391.97 Billion By 2025

The global architectural services market is expected to reach USD 391.97 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investments in construction sector has been a major factor driving market growth. Some major technological innovations in the market such as use of advanced designing and planning software’s have contributed largely to the market growth.

Due to the significant advancements in the level of building design, along with regulations and policies, the architectural services will witness a spur in the demand for highly technical design development along with accurate drafting services. This would initiate the demand for contractual service offerings. These contractual services will combat the complicated mechanical and electrical requirements and will also need high level analysis of pre-design services.

Residential sector accounted for a major shareholder in architectural services market, however Government sector is anticipated to grow substantially at a CAGR of 9.1% by 2025. Increasing investments by various government bodies across the world especially in projects such as smart cities, public transportation and subsidised home projects are driving the market growth for architectural services in government sector.

In 2016, Asia Pacific region accounted for maximum market share followed by Europe. Middle East and Africa region is anticipated to grow fastest over the forecast period, owing to increasing number of mega construction projects in the region.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/architectural-services-market

Further key findings from the report suggest:

  • Global demand for construction and project management architectural services was USD 107.61 billion in 2016 and is anticipated to witness staggered growth over the next nine years
  • The architectural services in education sector is anticipated to grow at CAGR of 8.0% over the forecast period.
  • The Asia Pacific market is projected to witness substantial growth over the next decade owing to various developments across major economies, especially in urban planning services market. The regional market is expected to grow at a CAGR of 3.6% from 2017 to 2025.
  • Key players including AECOM, Aedas, Gensler, IBI Group Inc., Nikken Sekkei dominated the global architectural services market while accounting for over 35% of the total revenue in 2016

Pressure Relief Devices Market Size Worth $4.1 Billion By 2025

The global pressure relief devices market size is expected to reach USD 4.1 billion by 2025, according to a new study by Grand View Research Inc. The rapidly growing number of elderly population worldwide and rising awareness about pressure ulcers through campaigns along with the increasing base of obese population are expected to drive the industry growth.

The incidence of pressure ulcer development has been rising since the past few years in hospital settings. According to a 2013 study by the Centers for Medicare and Medicaid Services (CMS), healthcare expenditure on hospital-acquired illnesses, including bedsores has increased at a rate of 7% from 2000 to 2013.

Geriatric population is prone to developing bed sores due to impaired mobility. Similarly, obese patients are at higher risk of ulcer development as they are required to stay in hospitals for prolonged periods. The limited mobility amongst these target populations will drive growth in this industry.

Creating awareness about pressure ulcer development is crucial since they are avoidable with proper precautions. Various campaigns such as ‘Stop the Pressure’ have been arranged by the governments to spread the awareness about pressure relief amongst patients and care providers. More than 2.5 million people in the U.S. and 0.7 million people in UK are affected by pressure ulcers every year.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/pressure-relief-device-market

Further Key Findings From the Study Suggest:

  • Low-tech devices have been identified as the largest type of segment in terms of revenue share, due to easier accessibility and cost-effectiveness of the devices
  • The focus on technically advanced innovative solutions is considered as the contributing factor to growth of low tech mattresses, especially gel-based mattresses and foam-based mattresses
  • High-tech devices have been projected as the fastest growing segment over the forecast period followed by low-tech mattresses, due to improved technical features
  • Amongst the types of low-tech mattresses, foam-based mattresses held the majority of market share in 2015 in terms of revenue owing to the high comfort and low technological complexity, and affordability
  • On the other hand, gel-based mattresses are expected to be the fastest growing low-tech devices over the forecast period
  • Dynamic air therapy beds were identified as the largest high-tech segment, while kinetic beds are projected to be the fastest growing segment, owing to the high efficiency and technical advancements
  • Key players in pressure relief devices market include ArjoHuntleigh; Hill-Rom Holdings, Inc.; Stryker; PARAMOUNT BED CO., LTD.; and Invacare Corporation 

Anxiety Disorders & Depression Treatment Market Worth $18.3 Billion By 2025

The global anxiety disorders and depression treatment market is expected to reach a value of USD 18.3 billion by 2025. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.

The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/anxiety-disorders-and-depression-treatment-market

Further key findings from the study suggest:

  • Presently, the antidepressant drugs segment holds the largest revenue share. However, due to the rising occurrence of adverse events associated with these therapeutics, this segment’s growth is expected to wane
  • Patent expiration of branded medicines and the introduction of generic biosimilars, which are cost-effective, are responsible for the shrinking market of antidepressants
  • On the other hand, the introduction of new medicines, such as Duloxetine, Fetzima, and Brintellix, is predicted to fuel the demand for therapeutics in the coming years 
  • Furthermore, the personalized therapies and devices segment is expected to register the fastest growth owing to its growing adoption by healthcare professionals as they exert fewer side effects as compared to drugs
  • Cognitive-behavioral therapy held the majority share in 2015 and is expected to register substantial growth in the coming years owing to the shifting preference of healthcare professionals toward this segment
  • Transcranial Magnetic Stimulation (TMS) is predicted to witness lucrative growth due to the introduction of technologically advanced devices such as MagVita TMS Therapy System by MagVenture in July 2015 and Brainsway Deep TMS in January 2013
  • North American regional segment for anxiety disorders and depression treatment reached a saturation level owing to the availability of several medicines and the high prevalence of depressive disorders in this region
  • Pfizer, Inc.; Eli Lilly and Company;GlaxoSmithKline plc; AstraZeneca; and H. Lundbeck A/S captured a sizable share in 2015 and accounted for more than 60% of the antidepressant drugs vertical
  • The revenue captured by antidepressants is expected to decrease with generics dominating the market during the forecast period

HIV Diagnostics Market Is Expected To Reach USD 4.48 Billion In 2022

Global HIV Diagnostics Market is expected to reach USD 4.48 billion by 2022, growing at an estimated CAGR of 9.5% from 2015 to 2022, according to a new study by Grand View Research, Inc. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource limited settings. Technological development of tests which is expected to introduce a number of novel rapid, point-of-care tests throughout the forecast period is a primary factor expected to fuel the growth of the HIV diagnostics market. Furthermore, government programs and campaigns initiated against HIV, global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in the Middle Eastern and Eastern regions of the market are some key factors expected to serve as lucrative future growth opportunities.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/hiv-diagnostics-market

Further key findings from the study suggest:

  • Antibody HIV diagnostic tests accounted for the largest share of the market in 2014. This large share can be accounted for by the high market usage and penetration rates of these tests which include, ELISA, home access dried blood spot, western blot testing IFA and RIPA.  These tests are highly sensitive and accurate and thus are most commonly used for screening and confirmation of HIV-1 & HIV-2.
  • Viral Load testing and CD4 testing also accounted for a considerable share of the market in 2014. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature and portable to the point of care to enhance their market usability and accessibility in resource limited HIV affected regions.
  • It is expected that during the forecast period a number of novel point of care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products s expected to fuel the growth of this market over the forecast period.
  • North America was observed to account for the largest share of the market in 2014, which can be attributed to the presence of a strong healthcare R&D scenario in which the presence of government funding and ongoing corporate efforts to enhance product portfolio are anticipated to accelerate the timelines for new product development. Furthermore, the presence of favorable reimbursements policies for HIV and other infectious diseases is also a factor accounting for this region’s large share.
  • Asia Pacific is expected to grow at a relatively faster rate over the forecast period owing to, the presence of high levels of unmet market demand for HIV screening and testing. Moreover, collaborations among market participants from the western regions is another significant expected to boost the growth of Asia Pacific HIV diagnostics market during the forecast period.
  • Key players of the market include Janssen Diagnostics, Daktari Diagnostics, Cepheid, Hologic and Chembio Diagnostic Systmes Inc.

Respiratory Syncytial Virus Diagnostics Market To Reach $1.2 Billion By 2022

Global Respiratory Syncytial Virus (RSV) diagnostics market is expected to reach USD 1.2 billion by 2022, according to a new study by Grand View Research Inc. Increasing neonatal population suffering from respiratory conditions including RSV infections and supportive initiatives for diagnosis of newborns by the healthcare providers are expected to be vital impact rendering drivers for RSV diagnostics market.

According to the statistics provided by the WHO, hospitalization of over 150,000 children (below the age of five) and about 14,000 deaths in geriatric patients occurred in the U.S. in 2014 due to RSV infections. This is anticipated to trigger demand for testing of these conditions over the forecast period.

Furthermore, the global birth rate as of 2014 is 18.7 births per 1,000 individuals, which is predicted to increase the infant population substantially over the next seven years. According to the statistics, it is estimated that about 134.2 million births took place in 2014, which are prone to RSV infections and require diagnosis, thus forming a large market base.

In 2010, Save Babies Through Screening Foundation (SBTS) entered in a partnership with World Solutions Against Infectious Disease (WSAID) as an attempt to promote higher screening of newborns for infectious diseases, metabolic disorders, and hearing disabilities.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/respiratory-syncytial-virus-diagnostics-market

Further key findings from the study suggest:

  • Chromatographic immunoassay technology based products are expected to witness the fastest growth at a CAGR above 10.0% over the next seven years owing to their higher specificity than molecular diagnostic products. The commercially available test kits include Binax Now RSV, QuickLab RSV Test, Remel Xpect, and RSV Respi-Strip.
  • Hospitals are predicted to dominate the RSV diagnostics market followed by home care. Together, they are expected to contribute over 50.0% of the market share in 2022. Increasing demand for home care diagnostic devices by patients is anticipated to drive growth of the segment over the next seven years.
  • North America is anticipated to dominate the market and contribute a revenue share of over 40.0% by 2022. Rising awareness among the population base and favorable initiatives by the government agencies such as the WHO, PAHO, and WSAID to initiate and implement newborn screening are expected to drive growth.
  • Key players of the market include Alere Inc., EMD Millipore, BD and Company, Ortho Clinical Diagnostics, Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific Inc. CLIA waiver and launch of RSV assays by companies like Roche Diagnostics, Becton Dickinson and Company, and Alere Inc. are expected to boost market growth over the forecast period.